We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our
Privacy Policy
Profacgen provides science-based Post-Market & Regulatory Support services for protein therapeutics, biologics, biosimilars, and related products after marketing authorization. Our programs support post-approval change assessment, comparability and bridging studies, lifecycle documentation, ongoing stability evaluation, continued process verification, and technical response materials for regulatory questions.
Post-approval lifecycle management connects manufacturing control, product quality, analytical evidence, stability commitments, and regulatory documentation. Manufacturing site transfers, equipment or scale changes, analytical method updates, specification revisions, formulation adjustments, packaging changes, and shelf-life updates may all require structured technical evaluation before implementation.
Scope note: Profacgen supports scientific, CMC, analytical, quality, and technical documentation activities. Final regulatory classification, legal review, submission decisions, authority communication, and compliance responsibilities remain with the sponsor or marketing authorization holder.
Why Post-Market Regulatory Support Matters
Market authorization does not end the need for product and process understanding. Changes made after approval can affect critical quality attributes, process consistency, analytical control, stability, or previously approved regulatory commitments. A structured post-market support program helps sponsors organize available knowledge, identify evidence gaps, and prepare traceable documentation for internal governance and regulatory review.
Key considerations in post-market programs include:
Change impact: Evaluation of how a proposed change may affect identity, strength, quality, purity, potency, stability, or process performance
Critical Quality Attributes (CQAs): Risk-based identification of product attributes most relevant to safety, efficacy, and mechanism of action
Comparability evidence: Side-by-side analytical, functional, process, and stability assessment of pre- and post-change materials where appropriate
Regulatory commitments: Review of approved conditions, stability commitments, validation status, and prior authority communications
Traceable documentation: Clear linkage between the proposed change, risk assessment, study design, results, conclusions, and post-change monitoring
Regional context: Documentation organized with awareness of applicable FDA, EU, and ICH frameworks while preserving sponsor control of final regulatory decisions
Service Scope and Responsibility Boundaries
Profacgen's post-market support services are designed to provide technical and documentation assistance without replacing the sponsor's regulatory, legal, pharmacovigilance, or quality responsibilities.
Profacgen can support: scientific rationales, quality risk assessments, comparability protocols, study reports, data summaries, present/proposed comparisons, response-support matrices, and technical sections for sponsor review
The sponsor or marketing authorization holder retains responsibility for: final filing category, regulatory strategy, legal interpretation, authority communication, submission content approval, and implementation decisions
Out of scope unless separately agreed: legal advice, pharmacovigilance case processing, safety-signal management, electronic publishing, and direct submission to regulatory authorities
Informational content: material on this page does not constitute legal or regulatory advice; current regional requirements should be confirmed before implementation
A Science- and Risk-Based Regulatory Framework
Profacgen organizes post-market support around the product type, target market, lifecycle stage, and proposed change. The applicable framework may include FDA post-approval change requirements, EU variation procedures, and ICH lifecycle-management principles. Final reporting requirements depend on the product, region, change type, and current authority guidance.
United States: Technical support for CMC changes affecting approved NDAs, ANDAs, or BLAs, including change descriptions, comparability protocols, present/proposed comparisons, and supplement or annual-report support materials
European Union: Technical documentation support for quality variations, grouped changes, and post-authorization evidence packages under the applicable variations framework
ICH-aligned programs: Risk-based use of ICH Q5E, Q8(R2), Q9(R1), Q10, and Q12 concepts to connect product knowledge, Established Conditions, comparability evidence, and pharmaceutical quality system controls
Multi-region changes: Evidence mapping that identifies common technical content and region-specific documentation needs for sponsor-controlled regulatory planning
Our Post-Market Support Workflow
Each program begins with a defined change, lifecycle question, or regulatory information request. The workflow is adjusted to the product, available data, target markets, and sponsor timeline.
Core Post-Market Service Categories
Profacgen supports six connected service domains. Modules can be used independently or combined into a broader lifecycle support program.
Post-Approval Change Assessment
Technical evaluation of proposed manufacturing, analytical, facility, equipment, specification, formulation, packaging, or supply-chain changes.
Change description and present/proposed comparison
Quality risk assessment and affected-system mapping
Evidence-gap identification and data-requirement planning
Regional reporting-category considerations for sponsor review
Implementation and post-change monitoring recommendations
Comparability & Bridging Study Support
Design and documentation of pre-/post-change comparability programs for biologics and protein-based products.
CQA selection and risk-based study design
Side-by-side analytical and functional comparison
Method bridging and reference-standard considerations
Process-performance and batch-consistency evaluation
Comparability protocols, reports, and residual-risk summaries
PACMP & Product Lifecycle Documentation
Support for prospective change planning and transparent product lifecycle documentation.
Post-Approval Change Management Protocol drafting support
Established Conditions and supporting-information mapping
Product Lifecycle Management document maintenance support
Change history, commitments, and knowledge-management summaries
Protocol-execution status and lifecycle action tracking
Continued Process Verification & Quality Trending
Technical support for ongoing process and product monitoring after approval.
Continued Process Verification data review and trend-analysis support
Annual product quality review technical summaries
Deviation, OOS/OOT, and CAPA data organization
Control-chart interpretation and investigation support materials
Control-strategy and monitoring-plan gap assessment
Ongoing Stability & Shelf-Life Support
Evaluation of post-approval stability programs, protocol updates, commitments, and data packages.
Long-term, accelerated, and stress-stability data review
Stability protocol or commitment update support
Shelf-life and retest-period technical justification support
Trending, out-of-trend assessment, and expiry-change documentation
Container-closure, hold-time, and transport-study support
Regulatory Query & Inspection-Readiness Support
Organization of technical evidence for information requests, deficiency responses, and inspection preparation.
Question-to-evidence mapping and response matrices
Data traceability and cross-reference review
Technical gap assessment and remediation documentation
Inspection-readiness summaries for CMC and quality topics
Source-data packages and appendix organization
Technical Capabilities for Post-Market Programs
Post-market support may require a combination of CMC documentation, analytical science, process knowledge, statistical evaluation, and quality-system awareness. Profacgen structures each package around the product, change type, and target market.
CMC and regulatory documentation: Change-control narratives, present/proposed tables, regulatory impact assessments, Module 3 technical summaries, annual-report support packages, and variation documentation drafts
Analytical comparability: Purity, charge, size, glycan, higher-order structure, post-translational modification, potency, and functional-assay comparison using relevant orthogonal methods
Statistics and data interpretation: Equivalence testing, tolerance intervals, quality-range analysis, multi-lot variability assessment, control charts, trend interpretation, and acceptance-criteria justification support
Stability evidence: Stability data compilation, statistical review, shelf-life update support, protocol revision support, and storage-condition or container-closure assessments
Process and quality monitoring: CPV plans and reports, annual product quality review summaries, method performance trending, reference-standard trending, and control-strategy review
Post-market and regulatory support can be applied to routine lifecycle maintenance, planned improvement projects, and unexpected technical or regulatory questions.
Manufacturing site transfer: Change assessment, comparability planning, analytical bridging, process review, stability strategy, and technical documentation
Scale or equipment change: Parameter comparison, CPP/CQA risk mapping, process-performance evaluation, and post-change monitoring planning
Analytical method update: Method comparison, bridging design, validation or verification data review, and technical summaries for the proposed method change
Specification revision: Historical data review, statistical analysis, quality relevance assessment, and acceptance-criteria rationale support
Stability or shelf-life update: Protocol review, stability trend analysis, expiry-support data organization, and submission-support drafts
Science- and Risk-Based Scope: Programs begin with the product, proposed change, target markets, and available knowledge rather than a fixed checklist.
Biologics-Focused Perspective: Support reflects the structural complexity, process sensitivity, analytical needs, and comparability considerations of protein-based products.
Traceable Documentation: Conclusions are linked to protocols, reports, datasets, change-history records, and regulatory commitments for easier review.
Cross-Functional Coordination: CMC, analytical, quality, manufacturing, and regulatory stakeholders can work from a shared evidence map.
Regional Awareness: Documentation can be organized around FDA, EU, and ICH concepts while preserving sponsor control of final classification and submission decisions.
Defined Boundaries: Profacgen provides technical support and documentation; we do not present service deliverables as regulatory approval or legal advice.
Related Service Pathways
Post-market support connects directly with earlier development, manufacturing, QC, and comparability activities.
Discovery & Early Development
Early product knowledge, target characterization, and developability evidence that support later lifecycle decisions.
A: Post-market regulatory support covers technical and documentation activities needed after a product receives marketing authorization. For CMC-focused programs, this may include change assessment, comparability studies, stability evaluation, continued process verification, dossier updates, and response-support materials for authority questions.
Q: What types of post-approval changes can Profacgen support?
A: Common examples include manufacturing site transfers, process or equipment changes, scale adjustments, analytical method updates, specification revisions, formulation or packaging changes, stability protocol updates, and biosimilar post-approval comparability activities. Scope is confirmed case by case.
Q: Can Profacgen determine the final regulatory filing category?
A: Profacgen can prepare a technical assessment and identify relevant regulatory considerations, but the sponsor or marketing authorization holder is responsible for final classification and submission decisions. Requirements vary by region, product, change type, and current authority guidance.
Q: How is ICH Q12 used in post-market lifecycle management?
A: ICH Q12 introduces lifecycle-management tools such as Established Conditions, Post-Approval Change Management Protocols, and Product Lifecycle Management documents. Profacgen can help map product knowledge, prepare supporting technical content, and organize documentation for sponsor review and regional implementation.
Q: What is the difference between comparability and analytical similarity?
A: Analytical similarity generally refers to the head-to-head comparison of a biosimilar candidate with a reference product. Comparability usually evaluates whether a product remains comparable before and after a manufacturing or process change. Both rely on risk-based analytical and functional evidence, but their regulatory context and study objectives differ.
Q: Do you prepare complete regulatory submissions?
A: Profacgen can prepare technical sections, evidence summaries, cross-reference tables, study protocols, and reports that support sponsor-controlled submissions. Final regulatory authoring, legal review, electronic publishing, and submission are typically managed by the sponsor or its authorized regulatory representative.
Q: Does this service include pharmacovigilance or safety reporting?
A: This page focuses on CMC, analytical, quality, stability, and lifecycle documentation support. Pharmacovigilance obligations, adverse-event reporting, and safety-signal management remain with the sponsor's qualified pharmacovigilance and regulatory functions.
Q: What information is needed to start a post-market support project?
A: Helpful starting materials include the approved indication and product type, target markets, proposed change description, relevant dossier sections, batch history, analytical methods, stability data, process performance data, previous authority commitments, and the sponsor's target timeline.
Online Inquiry
Fill out this form and one of our experts will respond to you within one business day.
